Trevi Therapeutics (TRVI) Net Equity Issued and Repurchased (2019)

Trevi Therapeutics' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $10.0 million for Q1 2019.

• In Q1 2019, Net Equity Issued and Repurchased changed N/A year-over-year to $10.0 million; the TTM figure through Dec 2019 stood at $10.0 million (changed N/A YoY), while the FY2019 annual figure was $10.0 million, down 5.08% from the prior year.
• Net Equity Issued and Repurchased for Q1 2019 stood at $10.0 million.
• The five-year high for Net Equity Issued and Repurchased was $10.0 million in Q1 2019, with the low at $10.0 million in Q1 2019.